Presentation: Andrew Stubbs

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Dr Andy Stubbs the Senior Medical Director at Dendreon joined us at the World Vaccine Congress Washington to talk to us about Sipuleucel-T, an autologous Cellular Immunotherapy for patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.

Dr Stubbs guided us through the following:

Dendreon and Provenge update:

• Who is using Provenge, how are patients selected, and how are they dealing with capacity restrictions?
• Combination strategies: What are the next steps to improve survival?
• Manufacturing facilities outside US: How is the GSK facility working in practice? What supply goes where?
• Looking back over the past year – what lessons have been learned and what does the future hold?

Download the full presentation here to discover more!

Presentation: Andrew Stubbs

information we require

please check before submitting